SOUTH SAN FRANCISCO, Calif., May 28, 2020 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on our Probody® therapeutic technology platform, announced today that Sean McCarthy, D.Phil., president, chief executive officer and chairman, will participate in the following virtual healthcare conferences in June.
Jefferies Virtual Healthcare ConferenceDr. McCarthy will present a Corporate Update
Goldman Sachs 41st Annual Global Healthcare Conference WebcastDr. McCarthy will participate in a Fireside Chat
A live audio webcast of the presentation and fireside chat will be available through the Events and Presentations page of CytomX’s website at www.CytomX.com. An archived replay will be available for 90 days following the event.About CytomX TherapeuticsInvestor and Media Contact:
Bay Street News
